Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes

INTRODUCTION: Delayed-release dimethyl fumarate (DMF) is an effective treatment for multiple sclerosis (MS). Some patients experience gastrointestinal (GI) adverse events (AEs) that may lead to premature DMF discontinuation. This study characterized the impact of site-specific GI management strategi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Ther
Main Authors: Min, Jinny, Cohan, Stanley, Alvarez, Enrique, Sloane, Jacob, Phillips, J. Theodore, van der Walt, Anneke, Koulinska, Irene, Fang, Fang, Miller, Catherine, Chan, Andrew
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534646/
https://ncbi.nlm.nih.gov/pubmed/30706431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-019-0127-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados